-
1.
Influence of a Training Academy on the Parasympathetic Nervous System Reactivation of Firefighter Recruits-An Observational Cohort Study.
Cornell, DJ, Noel, SE, Zhang, X, Ebersole, KT
International journal of environmental research and public health. 2020;(1)
Abstract
Sudden cardiac death (SCD) is the leading type of line-of-duty death among firefighters. An inability to restore parasympathetic nervous system (PSNS) control after activity is associated with SCD. Post-exercise heart rate recovery (HRR) provides unique insight into reactivation of the PSNS. Thus, the purpose of this study was to examine longitudinal changes in HRR responses of 25 male firefighter recruits. HR data were collected after submaximal exercise at week 1 (W1), week 6 (W6), and week 15 (W15) of their training at an academy. Percent maximal heart rate (%MHR) measures were computed at each HRR time point (%MHR0, %MHR15, %MHR30, %MHR45, %MHR60, %MHR120, %MHR180) and absolute HRR values were calculated at 30 s (ΔHRR30), 60 s (ΔHRR60), 120 s (ΔHRR120), and 180 s (ΔHRR180). After controlling for age and percent body fat, there was no statistically significant interaction between Week × HRR (p = 0.730), and there were no changes in ΔHRR30, ΔHRR60, and ΔHRR120, and ΔHRR180 indices across time. However, %MHR at W6 and W15 was significantly lower than %MHR at W1 at every HRR time point (ps < 0.001). Therefore, although the firefighter recruit training academy elicited positive training adaptations, changes in PSNS reactivation after submaximal activity were not identified.
-
2.
An increasingly complex view of intestinal motility.
Rao, M
Nature reviews. Gastroenterology & hepatology. 2020;(2):72-73
-
3.
Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial.
Shimizu, W, Kubota, Y, Hoshika, Y, Mozawa, K, Tara, S, Tokita, Y, Yodogawa, K, Iwasaki, YK, Yamamoto, T, Takano, H, et al
Cardiovascular diabetology. 2020;(1):148
Abstract
BACKGROUND Protection from lethal ventricular arrhythmias leading to sudden cardiac death (SCD) is a crucial challenge after acute myocardial infarction (AMI). Cardiac sympathetic and parasympathetic activity can be noninvasively assessed using heart rate variability (HRV) and heart rate turbulence (HRT). The EMBODY trial was designed to determine whether the Sodium-glucose cotransporter 2 (SGLT2) inhibitor improves cardiac nerve activity. METHODS This prospective, multicenter, randomized, double-blind, placebo-controlled trial included patients with AMI and type 2 diabetes mellitus (T2DM) in Japan; 105 patients were randomized (1:1) to receive once-daily 10-mg empagliflozin or placebo. The primary endpoints were changes in HRV, e.g., the standard deviation of all 5-min mean normal RR intervals (SDANN) and the low-frequency-to-high-frequency (LF/HF) ratio from baseline to 24 weeks. Secondary endpoints were changes in other sudden cardiac death (SCD) surrogate markers such as HRT. RESULTS Overall, 96 patients were included (46, empagliflozin group; 50, placebo group). The changes in SDANN were + 11.6 and + 9.1 ms in the empagliflozin (P = 0.02) and placebo groups (P = 0.06), respectively. Change in LF/HF ratio was - 0.57 and - 0.17 in the empagliflozin (P = 0.01) and placebo groups (P = 0.43), respectively. Significant improvement was noted in HRT only in the empagliflozin group (P = 0.01). Whereas intergroup comparison on HRV and HRT showed no significant difference between the empagliflozin and placebo groups. Compared with the placebo group, the empagliflozin group showed significant decreases in body weight, systolic blood pressure, and uric acid. In the empagliflozin group, no adverse events were observed. CONCLUSIONS This is the first randomized clinical data to evaluate the effect of empagliflozin on cardiac sympathetic and parasympathetic activity in patients with T2DM and AMI. Early SGLT2 inhibitor administration in AMI patients with T2DM might be effective in improving cardiac nerve activity without any adverse events. TRIAL REGISTRATION The EMBODY trial was registered by the UMIN in November 2017 (ID: 000030158). UMIN000030158; https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034442 .
-
4.
The effects of varying doses of caffeine on cardiac parasympathetic reactivation following an acute bout of anaerobic exercise in recreational athletes.
Sarshin, A, Naderi, A, da Cruz, CJG, Feizolahi, F, Forbes, SC, Candow, DG, Mohammadgholian, E, Amiri, M, Jafari, N, Rahimi, A, et al
Journal of the International Society of Sports Nutrition. 2020;(1):44
Abstract
BACKGROUND To examine the effects of varying doses of caffeine on autonomic reactivation following anaerobic exercise. METHODS Recreationally active males (N = 20; 24 ± 2y) participated in a randomized, double-blind, placebo-controlled, crossover study where participants ingested: [1] Control (CON; no supplement), [2] a non-caffeinated placebo (PLA), [3] 3-mg∙kg- 1 of caffeine (CAF3) or [4] 6-mg∙kg- 1 of caffeine (CAF6) prior to Wingate testing. Parasympathetic (lnRMSSD, primary outcome) and global HRV (lnSDNN, secondary outcome) were assessed at rest (i.e., pre-ingestion), 45-min post-ingestion, and 5-min and 35-min post-exercise recovery. We used a GLM to assess mean (95% CI) changes from pre-ingestion baseline. RESULTS Overall, we observed a significant trend for lnRMSSD and lnSDNN (both, p = 0.001, ηp2 = 0.745). Forty-five minutes after treatment ingestion, we observed a significant increase in lnRMSSD for CAF3 (0.15 ms, 95%CI, 0.07,0.24) and CAF6 (0.16 ms, 95%CI, 0.06,0.25), both being significant (both, p < 0.004) vs. CON (- 0.02 ms, 95%CI, - 0.09,0.04). Five-minutes after exercise, all treatments demonstrated significant declines in lnRMSSD vs. baseline (all, p < 0.001). After 35-min of recovery, lnRMSSD returned to a level not significantly different than baseline for CAF3 (0.03 ms, 95%CI, - 0.05, 0.12) and CAF6 (- 0.03 ms, 95%CI, - 0.17, 0.10), while PLA (- 0.16 ms, 95%CI, - 0.25, - 0.06) and CON (- 0.17 ms, 95%CI, - 0.28, - 0.07) treatments remained significantly depressed. A similar pattern was also observed for SDNN. CONCLUSION Caffeine ingestion increases resting cardiac autonomic modulation and accelerates post-exercise autonomic recovery after a bout of anaerobic exercise in recreationally active young men. However, no differences between caffeine doses on cardiac autonomic reactivity were observed.
-
5.
Caffeine increases parasympathetic reactivation without altering resting and exercise cardiac parasympathetic modulation: A balanced placebo design.
da Silva Rolim, P, da Costa Matos, RA, Von Koenig Soares, EMK, Molina, GE, da Cruz, CJG
European journal of sport science. 2019;(4):490-498
-
-
Free full text
-
Abstract
The sympathicotonic effect of caffeine is strongly evidenced in the literature. However, the effects of caffeine or caffeine expectancy on the cardiac parasympathetic modulation remain obscure. Thus, the aim of this study was to investigate the effects of caffeine consumption and expectancy of caffeine consumption on the cardiac parasympathetic modulation under different stress conditions. Twenty-one physically active men (22.3 ± 2.9 years, 25.2 ± 2.7 kg/m2) consumed ∼3 mg/kg of caffeine received as caffeine, caffeine as placebo, placebo as placebo and placebo as caffeine. Parasympathetic modulation was assessed by heart rate variability (HRV-Poincaré SD1 index) at supine and orthostatic positions, during a submaximal exercise (HRV threshold-HRVT) and during each 60 seconds (s) within 300 s of post-exercise active recovery. A factorial ANOVA for repeated measures (p < 0.05) was used to assess the effect of caffeine, expectancy and resting time after caffeine intake on the HRV. No significant effect of caffeine or expectancy was observed on the SD1 value at supine or standing positions (p = 0.47-0.53; p = 0.57-0.31, respectively), despite an increase in this variable after resting periods in both positions (p < 0.001). During exercise, caffeine and expectancy do not alter the HRVT (p = 0.51-0.39). However, higher SD1 values were observed after caffeine administration from 60 to 300 s post-exercise recovery (p = 0.01-0.05) but not for the effects of expectancy (p = 0.19-0.94). We concluded that low doses of caffeine or expectancy do not alter the resting cardiac parasympathetic modulation or HRVT. However, caffeine, but not expectancy, increases parasympathetic reactivation after a submaximal exercise test in young men.
-
6.
Higher energy intake at dinner decreases parasympathetic activity during nighttime sleep in menstruating women: A randomized controlled trial.
Tada, Y, Yoshizaki, T, Tanaka, I, Kanehara, R, Kato, M, Hatta, N, Hida, A, Kawano, Y
Physiology & behavior. 2018;:252-259
Abstract
BACKGROUND Previous studies have found more frequent increases in dietary intake and nonrestorative nocturnal sleep during the luteal phase than in the follicular phase, but few studies have investigated how increased energy intake at dinner influences sleep by considering the correlation between female hormone and cardiac autonomic nervous system (ANS) activity. This study examined the effects of energy intake at dinner on ANS activity during nighttime sleep in order to evaluate restorative sleep in healthy women. We also examined whether ANS activity is associated with female hormone dynamics. METHODS Twenty-four healthy collegiate women participated in this randomized crossover trial. Each was assigned to receive a High Energy Dinner (HED) or Low Energy Dinner (LED) treatment. Energy ratios of each test meal (breakfast, lunch, and dinner) to total energy intake were 1:1:2 and 1:2:1 for HED and LED treatments, respectively. Each participant wore an ECG recorder before dinner and removed it upon waking the next morning. Power spectral analysis of heart rate variability was used to calculate low frequency (LF), high frequency (HF), and total spectral power (TP). Cardiac sympathetic (SNS) and parasympathetic (PNS) nervous system activity were evaluated as LF/HF and HF/TP, respectively. RESULTS Mean HF/TP for the entire sleeping period was lower with HED treatment compared to LED treatment (41.7 ± 11.4 vs. 45.0 ± 12.13, P = .034). Intergroup comparisons of the initial 3-h sleeping period revealed that LF/HF (0.87 ± 0.82 vs. 0.66 ± 0.82, P = .013) and HF/TP (45.6 ± 13.9 vs. 51.5 ± 11.8, P = .002) were higher and lower, respectively, with HED treatment compared to LED treatment. Progesterone levels were positively correlated with LF/HF with LED treatment, and negatively correlated with HF/TP with both HED and LED treatments. CONCLUSION Higher energy intake at dinner increases and decreases SNS and PNS activities, respectively, resulting in nonrestorative nocturnal sleep. In addition, a negative correlation was observed between progesterone and PNS activity, highlighting the difficulty of increasing PNS activity during sleep in the luteal phase compared to the follicular phase.
-
7.
Constant hepatic ATP concentrations during prolonged fasting and absence of effects of Cerbomed Nemos® on parasympathetic tone and hepatic energy metabolism.
Gancheva, S, Bierwagen, A, Markgraf, DF, Bönhof, GJ, Murphy, KG, Hatziagelaki, E, Lundbom, J, Ziegler, D, Roden, M
Molecular metabolism. 2018;:71-79
Abstract
OBJECTIVE Brain insulin-induced improvement in glucose homeostasis has been proposed to be mediated by the parasympathetic nervous system. Non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) activating afferent branches of the vagus nerve may prevent hyperglycemia in diabetes models. We examined the effects of 14-min taVNS vs sham stimulation by Cerbomed Nemos® on glucose metabolism, lipids, and hepatic energy homeostasis in fasted healthy humans (n = 10, age 51 ± 6 yrs, BMI 25.5 ± 2.7 kg/m2). METHODS Heart rate variability (HRV), reflecting sympathetic and parasympathetic nerve activity, was measured before, during and after taVNS or sham stimulation. Endogenous glucose production was determined using [6,6-2H2]glucose, and hepatic concentrations of triglycerides (HCL), adenosine triphosphate (ATP), and inorganic phosphate (Pi) were quantified from 1H/31P magnetic resonance spectroscopy at baseline and for 180 min following stimulation. RESULTS taVNS did not affect circulating glucose, free fatty acids, insulin, glucagon, or pancreatic polypeptide. Rates of endogenous glucose production (P = 0.79), hepatic HCL, ATP, and Pi were also not different (P = 0.91, P = 0.48 and P = 0.24) between taVNS or sham stimulation. Hepatic HCL, ATP, and Pi remained constant during prolonged fasting for 3 h. No changes in heart rate or shift in cardiac autonomic function from HRV towards sympathetic or parasympathetic predominance were detected. CONCLUSION Non-invasive vagus stimulation by Cerbomed Nemos® does not acutely modulate the autonomic tone to the visceral organs and thereby does not affect hepatic glucose and energy metabolism. This technique is therefore unable to mimic brain insulin-mediated effects on peripheral homeostasis in humans.
-
8.
The Beneficial Effect of Parasympathetic Reactivation on Sympathetic Drive During Simulated Rugby Sevens.
Douglas, J, Plews, DJ, Handcock, PJ, Rehrer, NJ
International journal of sports physiology and performance. 2016;(4):480-8
Abstract
PURPOSE To determine whether a facilitated recovery via cold-water immersion (CWI) after simulated rugby sevens would influence parasympathetic reactivation and repeated-sprint (RS) performance across 6 matches in a 2-d tournament. METHODS Ten male team-sport athletes completed 6 rugby sevens match simulations over 2 d with either postmatch passive recovery (PAS) or CWI in a randomized crossover design. Parasympathetic reactivation was determined via the natural logarithm of the square root of the mean of the sum of the squares of differences between adjacent R-R intervals (ln rMSSD). RS performance was calculated as time taken (s) to complete 6 × 30-m sprints within the first half of each match. RESULTS There were large increases in postintervention ln rMSSD between CWI and PAS after all matches (ES 90% CL: +1.13; ±0.21). Average heart rate (HR) during the RS performance task (HRAverage RS) was impaired from baseline from match 3 onward for both conditions. However, HRAverage RS was higher with CWI than with PAS (ES 90% CL: 0.58; ±0.58). Peak HR during the RS performance task (HRPeak RS) was similarly impaired from baseline for match 3 onward during PAS and for match 4 onward with CWI. HRPeak RS was very likely higher with CWI than with PAS (ES 90% CL: +0.80; ±0.56). No effects of match or condition were observed for RS performance, although there were moderate correlations between the changes in HRAverage RS (r 90% CL: -0.33; ±0.14), HRPeak RS (r 90% CL: -0.38; ±0.13), and RS performance. CONCLUSION CWI facilitated cardiac parasympathetic reactivation after a simulated rugby sevens match. The decline in average and peak HR across matches was partially attenuated by CWI. This decline was moderately correlated with a reduction in RS performance.
-
9.
The dorsal motor nucleus of the vagus and regulation of pancreatic secretory function.
Mussa, BM, Verberne, AJ
Experimental physiology. 2013;(1):25-37
-
-
Free full text
-
Abstract
Recent investigation of the factors and pathways that are involved in regulation of pancreatic secretory function (PSF) has led to development of a pancreatic vagovagal reflex model. This model consists of three elements, including pancreatic vagal afferents, the dorsal motor nucleus of the vagus (DMV) and pancreatic vagal efferents. The DMV has been recognized as a major component of this model and so this review focuses on the role of this nucleus in regulation of PSF. Classically, the control of the PSF has been viewed as being dependent on gastrointestinal hormones and vagovagal reflex pathways. However, recent studies have suggested that these two mechanisms act synergistically to mediate pancreatic secretion. The DMV is the major source of vagal motor output to the pancreas, and this output is modulated by various neurotransmitters and synaptic inputs from other central autonomic regulatory circuits, including the nucleus of the solitary tract. Endogenously occurring excitatory (glutamate) and inhibitory amino acids (GABA) have a marked influence on DMV vagal output to the pancreas. In addition, a variety of neurotransmitters and receptors for gastrointestinal peptides and hormones have been localized in the DMV, emphasizing the direct and indirect involvement of this nucleus in control of PSF.
-
10.
Cardiac parasympathetic reactivation following exercise: implications for training prescription.
Stanley, J, Peake, JM, Buchheit, M
Sports medicine (Auckland, N.Z.). 2013;(12):1259-77
Abstract
The objective of exercise training is to initiate desirable physiological adaptations that ultimately enhance physical work capacity. Optimal training prescription requires an individualized approach, with an appropriate balance of training stimulus and recovery and optimal periodization. Recovery from exercise involves integrated physiological responses. The cardiovascular system plays a fundamental role in facilitating many of these responses, including thermoregulation and delivery/removal of nutrients and waste products. As a marker of cardiovascular recovery, cardiac parasympathetic reactivation following a training session is highly individualized. It appears to parallel the acute/intermediate recovery of the thermoregulatory and vascular systems, as described by the supercompensation theory. The physiological mechanisms underlying cardiac parasympathetic reactivation are not completely understood. However, changes in cardiac autonomic activity may provide a proxy measure of the changes in autonomic input into organs and (by default) the blood flow requirements to restore homeostasis. Metaboreflex stimulation (e.g. muscle and blood acidosis) is likely a key determinant of parasympathetic reactivation in the short term (0-90 min post-exercise), whereas baroreflex stimulation (e.g. exercise-induced changes in plasma volume) probably mediates parasympathetic reactivation in the intermediate term (1-48 h post-exercise). Cardiac parasympathetic reactivation does not appear to coincide with the recovery of all physiological systems (e.g. energy stores or the neuromuscular system). However, this may reflect the limited data currently available on parasympathetic reactivation following strength/resistance-based exercise of variable intensity. In this review, we quantitatively analyse post-exercise cardiac parasympathetic reactivation in athletes and healthy individuals following aerobic exercise, with respect to exercise intensity and duration, and fitness/training status. Our results demonstrate that the time required for complete cardiac autonomic recovery after a single aerobic-based training session is up to 24 h following low-intensity exercise, 24-48 h following threshold-intensity exercise and at least 48 h following high-intensity exercise. Based on limited data, exercise duration is unlikely to be the greatest determinant of cardiac parasympathetic reactivation. Cardiac autonomic recovery occurs more rapidly in individuals with greater aerobic fitness. Our data lend support to the concept that in conjunction with daily training logs, data on cardiac parasympathetic activity are useful for individualizing training programmes. In the final sections of this review, we provide recommendations for structuring training microcycles with reference to cardiac parasympathetic recovery kinetics. Ultimately, coaches should structure training programmes tailored to the unique recovery kinetics of each individual.